中国左心室辅助装置植入术后早期重症监护管理专家共识(2024年)  

Expert Consensus on Early Postoperative Intensive Care Management After Left Ventricular Assist Device Implantation(2024)

作　　者：中国生物医学工程学会机械循环支持分会 中国心室辅助装置专家共识委员会 胡盛寿 王现强 杜娟 邹亮 陈伊 周星彤 The Branch Mechanical Circulatory Support,Chinese Society of Biomedical Engineering;Chinese Expert Consensus Committee on Ventricular Assist Device;HU Shengshou;WANG Xianqiang

机构地区：[1]不详 [2]中国医学科学院阜外医院

出　　处：《中国循环杂志》2024年第8期729-750,共22页Chinese Circulation Journal

基　　金：中央高水平医院临床科研业务费(2022-GSP-QZ-7,2023-GSP-GG6);中国医学科学院阜外医院胡盛寿院士人工心脏及体外生命支持团队(SZSM201911018)。

摘　　要：左心室辅助装置(LVAD)是终末期心力衰竭的有效治疗措施,近年来在我国逐步推广。本专家共识总结了LVAD植入术后早期重症监护管理的最新认识及诊疗规范,包括进入重症监护病房时的交接、评估、心室辅助装置参数及问题、泵速调节、血液动力学监测及治疗、机械通气管理、出凝血管理、感染预防及治疗、心律失常及右心衰竭管理,以指导LVAD植入术后重症监护规范化管理,降低术后早期死亡率及并发症发生率,改善长期预后。The left ventricular assist device(LVAD)is an effective treatment modality for patients with advanced heart failure and has been gradually promoted in China in recent years.This expert consensus summarizes the latest understanding and diagnostic and treatment standards for intensive care management of patients with LVAD during the early post-implantation period,including handover upon admission to the intensive care unit(ICU),ICU evaluation,ventricular assist device related parameters and issues,pump speed regulation,hemodynamic monitoring and treatment,mechanical ventilation management,coagulation management,anti-infective prevention and treatment,arrhythmia and right heart failure management aiming to guide standardized ICU management after LVAD implantation,reduce early postoperative mortality and incidence of complications,and improve long-term prognosis.

关 键 词：左心室辅助装置 终末期心力衰竭 重症监护 血液动力学 右心衰竭 

分 类 号：R54[医药卫生—心血管疾病]